Cargando…

Sleep apnea and atrial fibrillation: Update 2020

Detalles Bibliográficos
Autores principales:	Linz, Dominik, Dobrev, Dobromir
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier 2020
Materias:	Commentary
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7708811/ https://www.ncbi.nlm.nih.gov/pubmed/33304991 http://dx.doi.org/10.1016/j.ijcha.2020.100681

Ejemplares similares

Personalized management of sleep apnea in patients with atrial fibrillation: An interdisciplinary and translational challenge
por: Linz, Dominik, et al.
Publicado: (2021)

Obstructive respiratory events during procedural sedation and analgesia: Another WHY to routinely screen for sleep apnea before catheter ablation of atrial fibrillation
por: Linz, Dominik, et al.
Publicado: (2021)

Outcome of atrial fibrillation ablation in pulmonary hypertension: Is pulmonary hypertension a modifiable risk factor?
por: Linz, Dominik, et al.
Publicado: (2019)

Nightly sleep apnea severity in patients with atrial fibrillation: Potential applications of long-term sleep apnea monitoring
por: Linz, Dominik, et al.
Publicado: (2019)

Gut-microbiota derived TMAO: A risk factor, a mediator or a bystander in the pathogenesis of atrial fibrillation?
por: Gawałko, Monika, et al.
Publicado: (2021)

Surgery-related cardiac stress: A susceptibility test of late atrial fibrillation recurrence?
por: Gawałko, Monika, et al.
Publicado: (2020)

Atrial fibrillation in sub-Saharan Africa: The knowns and unknowns?
por: Linz, Dominik, et al.
Publicado: (2019)

Safety and efficacy of vernakalant for acute cardioversion of atrial fibrillation: an update
por: Tsuji, Yukiomi, et al.
Publicado: (2013)

The gut microbial-derived metabolite trimethylamine N-oxide: A missing link between lifestyle-components and atrial fibrillation?
por: Gawałko, Monika, et al.
Publicado: (2020)

TGF-β1–induced endothelial-mesenchymal transition: a potential contributor to fibrotic remodeling in atrial fibrillation?
por: Saljic, Arnela, et al.
Publicado: (2022)

Central sleep apnea in atrial fibrillation: Risk factor or marker of untreated underlying disease?
por: Linz, Dominik, et al.
Publicado: (2020)

COVID-19 associated atrial fibrillation: Incidence, putative mechanisms and potential clinical implications
por: Gawałko, Monika, et al.
Publicado: (2020)

Obstructive Sleep Apnea and Atrial Arrhythmogenesis
por: Hohl, Mathias, et al.
Publicado: (2014)

Sleep Apnea and Atrial Fibrillation; 2012 Update
por: Digby, Genevieve C, et al.
Publicado: (2012)

Recent highlights on the prevalence and role of sleep disordered breathing in cardiovascular diseases from the International Journal of Cardiology Heart & Vasculature
por: Linz, Dominik, et al.
Publicado: (2023)

Undiagnosed sleep apnea in patients with atrial fibrillation: An underutilized opportunity for antiarrhythmic management
por: Hereijgers, Maartje J.M., et al.
Publicado: (2022)

Highlights from the International Journal of Cardiology Heart & Vasculature: Heart failure, atrial fibrillation, coronary artery disease and myocardial infarction
por: Linz, Dominik, et al.
Publicado: (2019)

Sleep apnea in atrial fibrillation – Highly prevalent, highly relevant, but most patients are not somnolent!
por: Kadhim, Kadhim, et al.
Publicado: (2020)

Atrial fibrillation and obstructive sleep apnea in African populations: uncovering a neglected association
por: Noubiap, Jean Jacques
Publicado: (2021)

Emerging Antiarrhythmic Drugs for Atrial Fibrillation
por: Saljic, Arnela, et al.
Publicado: (2022)

Antiarrhythmic drugs for atrial fibrillation: Imminent impulses are emerging
por: Dan, Gheorghe-Andrei, et al.
Publicado: (2018)

The temporal context of oral anticoagulation outcome in atrial fibrillation
por: Fender, Anke C., et al.
Publicado: (2022)

A disproportional rise in the growing submission rate to International Journal of Cardiology Heart & Vasculature during the COVID‑19 pandemic
por: Linz, Dominik, et al.
Publicado: (2021)

Altered Atrial Metabolism: An Underappreciated Contributor to the Initiation and Progression of Atrial Fibrillation
por: Ghezelbash, Shokoufeh, et al.
Publicado: (2015)

Bayesian network analyses in atrial fibrillation – A path to better therapies?()
por: Heijman, Jordi, et al.
Publicado: (2019)

Obstructive sleep apnea and atrial fibrillation
por: Todd, Keith, et al.
Publicado: (2010)

Obstructive Sleep Apnea and Atrial Fibrillation
por: Moula, Amalia Ioanna, et al.
Publicado: (2022)

Sleeping Beauty unravelled – Detection of sleep apnoea in patients with atrial fibrillation
por: Hendriks, Jeroen M., et al.
Publicado: (2023)

The State of Atrial Fibrillation in 2020
por: Doshi, Rahul N
Publicado: (2021)

Pleiotropic Effects of Antiarrhythmic Agents: Dronedarone in the Treatment of Atrial Fibrillation
por: Heijman, Jordi, et al.
Publicado: (2013)

Fat chance for POAF? Pericardial adipose tissue and the arrhythmogenic substrate for postoperative atrial fibrillation
por: Gawałko, Monika, et al.
Publicado: (2022)

Botulinum toxin for prevention of post-operative atrial fibrillation
por: Saljic, Arnela, et al.
Publicado: (2023)

Calcium dysregulation in atrial fibrillation: the role of CaMKII
por: Heijman, Jordi, et al.
Publicado: (2014)

Can cystatin C-based estimated glomerular filtration rate help to guide individualized risk factor modification programs?
por: Linz, Dominik, et al.
Publicado: (2018)

Does weight matter in cryoballoon ablation?
por: Gawałko, Monika, et al.
Publicado: (2023)

Inflammatory signalling in atrial cardiomyocytes: a novel unifying principle in atrial fibrillation pathophysiology
por: Dobrev, Dobromir, et al.
Publicado: (2022)

Genome-wide association studies of atrial fibrillation: Finding meaning in the life of risk loci
por: Sutanto, Henry, et al.
Publicado: (2019)

The Interplay between Obstructive Sleep Apnea and Atrial Fibrillation
por: Marulanda-Londoño, Erika, et al.
Publicado: (2017)

Breaking bad: Higher risk of osteoporosis with vitamin K antagonists compared to direct oral anticoagulants in patients with atrial fibrillation
por: Fender, Anke C., et al.
Publicado: (2020)

Anticoagulation in difficult settings RELOADed: Evidence for applicability of direct oral anticoagulants in patients with atrial fibrillation, renal impairment and cancer
por: Fender, Anke C., et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_8h9le4drpgo1b4luo8fpu08m7b